| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/03/2007 | US20070099249 Compositions and liquid crystals |
| 05/03/2007 | US20070099210 Methods of Labelling Polynucleotides with Dibenzorhodamine Dyes |
| 05/03/2007 | US20070098793 Oxymorphone controlled release formulations |
| 05/03/2007 | US20070098792 Oxymorphone controlled release formulations |
| 05/02/2007 | EP1778694A1 Tetrahydroquinolines |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 05/02/2007 | CN1956982A Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeleton |
| 05/02/2007 | CN1956955A Neurogenic pain control agent composition |
| 05/02/2007 | CN1956722A Improved cytotoxic agents comprising new maytansinoids |
| 05/02/2007 | CN1955183A 20-bit esterified camptothecine derivate, its preparation method and drug composite and use |
| 05/02/2007 | CN1955178A New benzimidazole derivative |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| 05/01/2007 | US7211672 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/01/2007 | US7211597 Antiinflammatory agents; rheumatic diseases; anticancer agents |
| 05/01/2007 | US7211580 Compounds, compositions, and methods |
| 05/01/2007 | CA2283587C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles |
| 05/01/2007 | CA2189524C Aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino-[2,3e]indol-8-ones and derivatives |
| 04/26/2007 | WO2007048002A2 Camptothecin derivatives as chemoradiosensitizing agents |
| 04/26/2007 | WO2007047306A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2007047207A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 04/26/2007 | WO2007046554A1 Process for production of dibenzoxepinopyrrole compound, intermediate for production of the compound, and process for production of the intermediate |
| 04/26/2007 | WO2007046456A1 Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 04/26/2007 | WO2006128268A8 Ureidic compounds, pharmaceutical compositions containing the same and their use on the treatment of inflammatory diseases |
| 04/26/2007 | WO2005082883A3 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline |
| 04/26/2007 | WO2004099203A8 Imidazopyridine intermediates |
| 04/26/2007 | US20070093652 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands |
| 04/26/2007 | US20070093521 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 04/26/2007 | US20070093432 Camptothecin derivatives as chemoradiosensitizing agents |
| 04/26/2007 | US20070092954 Production of polyketides |
| 04/26/2007 | US20070092453 Novel Crystalline Forms of Tiotropium Bromide |
| 04/26/2007 | CA2626595A1 Intermediate and process of preparation of ecteinascidin such as ecteinascidines-583, 597 using such intermediate |
| 04/26/2007 | CA2626330A1 Preventive or therapeutic agents for pancreatic cancer, ovarian cancer, or liver cancer comprising a novel water-solube prodrug |
| 04/26/2007 | CA2624904A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/25/2007 | EP1777222A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776982A1 Pyrimidine compounds as histamine modulators |
| 04/25/2007 | EP1776368A1 Inhibitors of hcv replication |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | CN1953982A 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones |
| 04/25/2007 | CN1953747A Diphenyl-indol-2-on compounds and their use in the treatment of cancer |
| 04/25/2007 | CN1312155C Method for separating and purifying 9-nitro camptothecin |
| 04/25/2007 | CN1312147C Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 04/24/2007 | US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein. |
| 04/24/2007 | US7208492 Topoisomerase-targeting agents |
| 04/24/2007 | US7208490 Having useful antibacterial activity against a wide range of human and veterinary pathogens; for therapy of microbial infections in mammals |
| 04/19/2007 | WO2007044885A2 Piperidine derivatives and methods of use |
| 04/19/2007 | WO2007044866A2 Water-soluble, fluorescent compounds for detection of potassium ions |
| 04/19/2007 | WO2007044804A2 Piperidine derivatives and methods of use |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007042906A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 04/19/2007 | WO2007042799A1 Novel crystalline forms |
| 04/19/2007 | WO2007042325A1 Antibacterial active 5-chinolin derivative |
| 04/19/2007 | WO2006101217A3 Luminous compound containing lanthanide ion |
| 04/19/2007 | US20070088159 Hydroxyalkyl cyclic diamine compounds |
| 04/19/2007 | US20070088064 Pharmaceutical composition containing bicyclic type compounds |
| 04/19/2007 | US20070088036 1-[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carbonitrile; -[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carboxylic acid methyl ester; deposited on a stent or stent-graft device |
| 04/19/2007 | US20070088031 Novel chemical compounds |
| 04/19/2007 | US20070088029 Tricycloundecane compounds useful as modulators of nuclear hormone receptor function |
| 04/19/2007 | US20070088025 Tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives as cannabinoid cb1 receptor agonists |
| 04/19/2007 | US20070088019 Macroheterocyclic compounds as kinase inhibitors |
| 04/19/2007 | US20070088018 Cb1 antagonist compounds |
| 04/19/2007 | US20070087396 Method of tacrolimus extraction and quantification using aqueous detergents |
| 04/19/2007 | CA2625687A1 Antibacterial active 5-chinolin derivative |
| 04/19/2007 | CA2624307A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/18/2007 | EP1773826A2 C-met modulators and method of use |
| 04/18/2007 | EP1773805A1 Quinazolin-4-yl-piperidine and cinnolin-4-yl-piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 04/18/2007 | EP1773795A1 Substituted benzothiazoles |
| 04/18/2007 | EP1773781A2 Indazoles useful in treating cardiovascular diseases |
| 04/18/2007 | EP1773345A2 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 04/18/2007 | EP1773343A1 Antibacterial agents |
| 04/18/2007 | EP1487839B1 Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof |
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 04/18/2007 | EP1353673B1 Camptothecin derivatives |
| 04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
| 04/18/2007 | CN1950378A Thienopyridazines as ikk inhibitors |
| 04/18/2007 | CN1950377A Thienopyridines as IKK inhibitors |
| 04/18/2007 | CN1950375A Glucocorticoid receptor modulator compounds and methods- utility |
| 04/18/2007 | CN1950081A Arylalkylamino-substituted quinazoline analogues |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/18/2007 | CN1310919C 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205408 Therapy for bacteria infections in mammals |
| 04/17/2007 | US7205334 vacuolar-type (H+)-ATPase-inhibiting macrocyclic lactams belonging to the chondropsin class useful in cancer chemotherapy |
| 04/17/2007 | US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide |
| 04/17/2007 | US7205316 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 04/12/2007 | WO2007041724A1 N-substituted 3,4-alkylenedioxypyrroles, ester substituted dihydroxypyrroles and methods for synthesis of these pyrroles |
| 04/12/2007 | WO2007041195A2 Macroheterocylic compounds as kinase inhibitors |
| 04/12/2007 | WO2007040650A2 Apoptosis promoters |
| 04/12/2007 | WO2007040282A1 Bridged cyclic amine compound and pest control agent |
| 04/12/2007 | WO2007040166A1 Novel fused pyrrole derivative |
| 04/12/2007 | WO2007040082A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 04/12/2007 | WO2007039609A1 Pyranodibenzofuran derivatives with antifungal and antibacterial activity |
| 04/12/2007 | WO2007039467A1 Pyrimidine compounds for the treatment of inflammatory disorders |
| 04/12/2007 | WO2007039438A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 04/12/2007 | WO2007039219A1 Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor |
| 04/12/2007 | WO2007039138A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 04/12/2007 | WO2007017585A3 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |